Wael Hozaeel

Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Beer Sheva 8410101
Beersheba, D 84101, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Surgery After Induction Therapy for Cervical Esophageal Cancer: A Systematic Review and Proposed Multidisciplinary Selection Framework.

Surgery After Induction Therapy for Cervical Esophageal Cancer: A Systematic Review and Proposed Multidisciplinary Selection Framework.

Journal: Cancers

Published: May 03, 2026

Prognostic Impact and Postoperative Management Following Poor Pathological Response to Perioperative FLOT in Resectable Gastric and GEJ Adenocarcinoma: A Systematic Review and Meta-Analysis.

Prognostic Impact and Postoperative Management Following Poor Pathological Response to Perioperative FLOT in Resectable Gastric and GEJ Adenocarcinoma: A Systematic Review and Meta-Analysis.

Journal: Journal of clinical medicine

Published: February 18, 2026

Clinical characteristics and outcomes of colorectal cancer in elderly patients, insights from a large database in Israel.

Clinical characteristics and outcomes of colorectal cancer in elderly patients, insights from a large database in Israel.

Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)

Published: July 05, 2025

Lynch Syndrome: Similarities and Differences of Recommendations in Published Guidelines.

Lynch Syndrome: Similarities and Differences of Recommendations in Published Guidelines.

Journal: Journal of gastroenterology and hepatology

Published: May 23, 2024

Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial.

Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial.

Journal: Annals of surgical oncology

Published: August 31, 2023

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.

Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.

Journal: Lancet (London, England)

Published: August 23, 2018

Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.

Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.

Journal: The Lancet. Oncology

Published: July 14, 2016

The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (QoliTax).

The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (QoliTax).

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: August 11, 2014

Combination of trastuzumab and triple FLOT chemotherapy (5-fluorouracil/leucovorin, oxaliplatin, and docetaxel) in patients with HER2-positive metastatic gastric cancer: report of 3 cases.

Combination of trastuzumab and triple FLOT chemotherapy (5-fluorouracil/leucovorin, oxaliplatin, and docetaxel) in patients with HER2-positive metastatic gastric cancer: report of 3 cases.

Journal: Onkologie

Published: September 26, 2012

Showing 1-9 of 9

Last Updated: 09/26/2026